|   GSK097 structure | Common Name | GSK097 | ||
|---|---|---|---|---|
| CAS Number | 2159137-02-5 | Molecular Weight | 339.39 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H21N3O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of GSK097GSK097 is a potent and selective Inhibitor of the second bromodomain (BD2) of the bromodomain and extra-terminal domain (BET) proteins. GSK097 displays 2000-fold selective for BD2 over BD1 (BRD4 data) with >1 mg/mL solubility in FaSSIF media[1]. | 
| Name | GSK097 | 
|---|
| Description | GSK097 is a potent and selective Inhibitor of the second bromodomain (BD2) of the bromodomain and extra-terminal domain (BET) proteins. GSK097 displays 2000-fold selective for BD2 over BD1 (BRD4 data) with >1 mg/mL solubility in FaSSIF media[1]. | 
|---|---|
| Related Catalog | |
| In Vitro | GSK097 displays pIC50s 7.4, 8.0, 7.6, and 7.9 for BRD2 BD2, BRD3 BD2, BRD4 BD2 and BRDT BD2, respectively[1]. | 
| References | 
| Molecular Formula | C19H21N3O3 | 
|---|---|
| Molecular Weight | 339.39 |